Forge Biologics · 1 month ago
Summer Intern - Analytical Development(Protein Assay Development)
Forge Biologics is a company focused on enabling access to life-changing gene therapies. They are seeking an Analytical Development Intern to support the analytical assay development team, gain hands-on experience in molecular biology techniques, and contribute to product characterization and method optimization.
BiotechnologyHealth CareMedicalTherapeutics
Responsibilities
You will assist with product characterization-related assays in support of AAV release and characterization, method development/optimization, methods transfer, and analytical support for gene therapy product process development and manufacturing
You will compile experimental data, generate reports, and archive assay data
You will apply relevant scientific principles and techniques to analytical development problems
You will maintain detailed, up to date, and reviewed laboratory notebooks to ensure the integrity of data
Qualification
Required
You are a current junior currently enrolled in a full-time bachelor's degree program from an accredited college or university with a 3.0 minimum GPA or equivalent
You are studying Molecular Biology, Cell Biology, Biochemistry, Biomedical Engineering, or related field
You are a self-starter, collaborative, detail-oriented and inquisitive
You have enthusiasm to learn
Preferred
Previous laboratory or research experience is a plus
Company
Forge Biologics
Forge Biologics is a gene therapy development engine, enabling access to life changing gene therapy programs.
H1B Sponsorship
Forge Biologics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (7)
2024 (4)
2023 (2)
2022 (1)
Funding
Current Stage
Growth StageTotal Funding
$330MKey Investors
State of OhioMidCap FinancialRA Capital Management
2023-11-13Acquired
2022-09-12Series C· $90M
2022-01-10Grant
Leadership Team
Recent News
2025-12-24
Company data provided by crunchbase